Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Sarepta Therapeutics Inc (SRPT)

318 + Investors. Track Smart Money conviction in SRPT. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -16
Streak
2Q ▼
Buyers last Q
46%

Smart Money Signals — SRPT

Based on 329 hedge funds · latest filing: 2026 Q2 · updated quarterly

📉

Selling streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds reduced or closed their SRPT positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
🔻

Below peak — only 68% of 3.0Y high

68% of all-time peak
Only 329 funds hold SRPT today versus a peak of 484 funds at 2024 Q2 — just 68% of the maximum. Low institutional ownership can mean the stock is out of favor, but it also means there's a large pool of potential buyers if sentiment turns.
📉

Outflows — 10% fewer funds vs a year ago

fund count last 6Q
35 fewer hedge funds hold SRPT compared to a year ago (-10% decline). When institutions consistently reduce their exposure, it's worth exploring the underlying fundamental reasons driving them away.
🟠

More sellers than buyers — 46% buying

163 buying189 selling
Last quarter: 189 funds reduced or exited vs 163 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.
➡️

Steady new buyers — ~53 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 60 → 78 → 48 → 53. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔒

64% of holders stayed for 2+ years

■ 64% conviction (2yr+) ■ 19% medium ■ 17% new
210 out of 329 hedge funds have held SRPT for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares +1%, value -72%

Value
-72%
Shares
+1%
Last quarter: funds added +1% more shares while total portfolio value only changed -72%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
📊

Peak discovery — momentum slowing

67 → 60 → 78 → 48 → 53 new funds/Q
New funds entering each quarter: 60 → 78 → 48 → 53. SRPT is well-known in the hedge fund world, but fresh entries are gradually declining. The explosive phase of institutional discovery is likely behind us.
🏛️

Veteran-anchored — 71% veterans vs 17% newcomers

■ 71% veterans ■ 13% 1-2yr ■ 17% new
Entry-cohort mix of 346 holders: 244 (71%) are 2+ year veterans, 44 entered 1–2 years ago, and 58 (17%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 59% AUM from top-100 funds

59% from top-100 AUM funds
51 of 323 holders are among the 100 largest funds by AUM, controlling 59% of total institutional value in SRPT. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
2.0
out of 10
Low Exit Risk
Exit risk score 2.0/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — SRPT

In 2026 Q2, 163 hedge funds were net buyers of SRPT (53 opened a new position, 110 added to an existing one), while 189 reduced or exited (120 trimmed, 69 sold completely) — a 46% buyer ratio, indicating roughly balanced activity. Net selling has persisted for two consecutive quarters. 59% of total institutional value in SRPT is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: -16 funds (more exits than new entries). Total institutional holders: 329.

Hedge Fund Ownership: SRPT

How many hedge funds hold SRPT — quarterly history vs. share price
Quarterly hedge fund ownership of SRPT vs. share price

Market Analysis: SRPT

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: SRPT

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Sarepta Therapeutics Inc (SRPT) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much SRPT has moved relative to its sector benchmark (XLV) since the 2026 Q3 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End September 30, 2026 · 46d ago
SRPT
-12.0%
XLV
+12.1%

SRPT outperformed XLV by -24.1% since September 30, 2026.

Since 13F Filing Date November 14, 2026 · 1d ago
SRPT
+0.0%
XLV
+0.0%

Since the filing became public, SRPT outperformed XLV by +0.0% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

11 top-rated funds 1 high-conviction
Consensus
4.7
/ 10
breadth
×
Elite
1.4
/ 10
conviction
Hedge Fund Positioning: SRPT
2026 Q3 Stats Unlock in 4 days 318 + Investors

Track Smart Money conviction in SRPT. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 318 345 -7.83%
13F Shares 112M 113M -0.85%
Total Value $1.96B $7.55B -73.98%
New Positions 50 48 +2
Increased Positions 99 111 -12
Closed Positions 71 53 +18
Reduced Positions 116 132 -16
Total Calls 11 13 -15.38%
Total Puts 12 15 -20.0%
PUT/CALL Ratio 1.09 1.15 Neutral

Statistics: SRPT

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q3)

318 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in SRPT. Verified SEC 13F-HR filings.

QUARTER:
2026 Q3 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.
Top 25 SRPT holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Hussman Strategic Advisors, INC. 0.82% 210,000 $3.8M
2 Privium Fund Management B.V. 0.59% 166,605 $3.0M
3 Virtus Investment Advisers, LLC 0.44% 110,091 $2.0M
4 Virtus Advisers, LLC 0.39% 58,244 $1.1M
5 Erste Asset Management GmbH 0.31% 2,268,945 $42.1M
6 Bayforest Capital Ltd 0.23% 8,484 $155K
7 Deeter Investments LLP 0.19% 75,567 $1.4M
8 Generali Investments CEE, investicni spolecnost, a.s. 0.18% 211,850 $3.8M
9 CenterBook Partners LP 0.13% 153,853 $2.8M
10 China Universal Asset Management Co., Ltd. 0.08% 85,939 $1.6M
11 Atlantic Private Wealth, LLC 0.08% 7,500 $137K
12 Fulcrum Asset Management LLP 0.06% 73,180 $1.4M
13 Caitong International Asset Management Co., Ltd 0.06% 33,288 $607K
14 denkapparat Operations GmbH 0.06% 12,050 $220K
15 First Trust Advisors LP 0.05% 4,923,020 $89.7M
16 Advisory Research Inc 0.05% 27,265 $497K
17 Empowered Funds, LLC 0.05% 562,573 $10.3M
18 Federated Hermes, INC. 0.04% 1,580,941 $28.8M
19 Martingale Asset Management L P 0.04% 85,088 $1.6M
20 Panagora Asset Management Inc 0.04% 700,219 $12.8M
21 Quattro Financial Advisors LLC 0.04% 10,000 $182K
22 WINTON GROUP Ltd 0.03% 46,777 $852K
23 Marshall Wace, LLP 0.03% 2,015,950 $36.7M
24 Catalyst Funds Management Pty Ltd 0.03% 15,915 $290K
25 New Age Alpha Advisors, LLC 0.03% 34,783 $634K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Stocks with similar institutional ownership

PRM 229 holdersFXH 229 holdersIMAX 229 holdersSUPN 229 holdersPOCT 229 holdersEZPW 229 holdersALG 228 holdersTU 228 holdersPRG 228 holdersIBOC 228 holdersCRK 228 holdersJMBS 228 holders All stocks →

Frequently Asked Questions — Sarepta Therapeutics Inc (SRPT)

What does the Smart Money Trend signal show for SRPT?

Selling streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds reduced or closed their SRPT positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for SRPT?

More sellers than buyers — 46% buying: Last quarter: 189 funds reduced or exited vs 163 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for SRPT holders?

Elite ownership — 59% AUM from top-100 funds: 51 of 323 holders are among the 100 largest funds by AUM, controlling 59% of total institutional value in SRPT. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held SRPT?

64% of holders stayed for 2+ years: 210 out of 329 hedge funds have held SRPT for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Sarepta Therapeutics Inc (SRPT) following the 2026 Q3 hedge fund 13F filings?

As of today, SRPT has moved +0.0% since the 2026 Q3 13F filing date (November 14, 2026), compared to +0.0% for the XLV sector ETF — an outperformance of +0.0%. Since the quarter end (September 30, 2026), SRPT has gained -12.0% vs +12.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →